We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.81%
3 Healthcare 8.45%
4 Industrials 6.22%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYC
3751
DELISTED
Blackrock Muni Yield California Fund, Inc.
MYC
$139K ﹤0.01%
10,644
ATCX
3752
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$138K ﹤0.01%
11,436
+123
+1% +$1.28K
INTZ
3753
DELISTED
INTRUSION INC NEW
INTZ
$138K ﹤0.01%
55,835
-1,036
-2% -$2.56K
SOL
3754
DELISTED
Emeren Group
SOL
$135K ﹤0.01%
23,289
+5,885
+34% +$34.7K
ARLO icon
3755
Arlo Technologies
ARLO
$1.52B
$134K ﹤0.01%
15,129
-26,347
-64% -$242K
JPM icon
3756
PUT
JPMorgan Chase
JPM
$969B
$134K ﹤0.01%
+25,500
New +$3.76M
HTBK
3757
DELISTED
Heritage Commerce
HTBK
$133K ﹤0.01%
11,827
+1,121
+10% +$13.4K
KHC icon
3758
CALL
Kraft Heinz
KHC
$29B
$133K ﹤0.01%
22,100
-14,600
-40% -$547K
CLS icon
3759
Celestica
CLS
$42.1B
$132K ﹤0.01%
+11,122
New +$131K
DMF
3760
DELISTED
BNY Mellon Municipal Income
DMF
$132K ﹤0.01%
17,445
-1,937
-10% -$15.5K
HBM icon
3761
Hudbay
HBM
$12.5B
$131K ﹤0.01%
+16,626
New +$129K
MCN
3762
Madison Covered Call & Equity Strategy Fund
MCN
$119M
$131K ﹤0.01%
16,582
-525
-3% -$4.12K
ACB
3763
Aurora Cannabis
ACB
$230M
$130K ﹤0.01%
3,246
+1,569
+94% +$66.5K
AROC icon
3764
Archrock
AROC
$5.85B
$130K ﹤0.01%
14,108
-405
-3% -$3.47K
RJF icon
3765
CALL
Raymond James Financial
RJF
$34.6B
$130K ﹤0.01%
16,000
-50
-0.3% -$5.3K
DSP icon
3766
Viant Technology
DSP
$268M
$128K ﹤0.01%
19,473
+4,481
+30% +$34.2K
HGTY icon
3767
Hagerty
HGTY
$1.29B
$128K ﹤0.01%
+11,850
New +$169K
IAF
3768
abrdn Australia Equity Fund
IAF
$128M
$128K ﹤0.01%
6,796
-364
-5% -$6.31K
RES icon
3769
RPC Inc
RES
$1.39B
$127K ﹤0.01%
+11,859
New +$94.6K
MCBC
3770
DELISTED
Macatawa Bank Corp
MCBC
$125K ﹤0.01%
13,912
+379
+3% +$3.48K
NFNT.U
3771
DELISTED
Infinite Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFNT.U
$125K ﹤0.01%
12,500
DHY
3772
Credit Suisse High Yield Credit Fund
DHY
$242M
$123K ﹤0.01%
56,585
NCV
3773
Virtus Convertible & Income Fund
NCV
$391M
$122K ﹤0.01%
6,064
+230
+4% +$4.72K
DCH
3774
Dauch Corp
DCH
$1.6B
$120K ﹤0.01%
15,481
+1,278
+9% +$10.9K
ONEM
3775
DELISTED
1Life Healthcare
ONEM
$120K ﹤0.01%
+10,787
New +$121K

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.